Cantor Fitzgerald Comments on Ardelyx FY2025 Earnings
Ardelyx, Inc. (NASDAQ:ARDX – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for Ardelyx in a research report issued on Tuesday, March 4th. Cantor Fitzgerald analyst P. Agrawal forecasts that the biopharmaceutical company will earn ($0.13) per share for the year. Cantor Fitzgerald currently has a “Strong-Buy” […]
Ardelyx, Inc. (NASDAQ:ARDX – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for Ardelyx in a research report issued on Tuesday, March 4th. Cantor Fitzgerald analyst P. Agrawal forecasts that the biopharmaceutical company will earn ($0.13) per share for the year. Cantor Fitzgerald currently has a “Strong-Buy” […]
